4//SEC Filing
Janku Filip 4
Accession 0000899243-21-025979
CIK 0001826457other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:00 PM ET
Size
5.4 KB
Accession
0000899243-21-025979
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-23+387,069→ 387,069 totalExercise: $19.00Exp: 2031-06-22→ Common Stock (387,069 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on June 1, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001862930
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:00 PM ET
- Size
- 5.4 KB